Citation: Bl. Davidson et Awa. Lensing, Should echocardiography of the right ventricle help determine who receivesthrombolysis for pulmonary embolism?, CHEST, 120(1), 2001, pp. 6-8
Authors:
Simioni, P
Prandoni, P
Lensing, AWA
Manfrin, D
Tormene, D
Gavasso, S
Girolami, B
Sardella, C
Prins, M
Girolami, A
Citation: P. Simioni et al., Risk for subsequent venous thromboembolic complications in carriers of theprothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis, BLOOD, 96(10), 2000, pp. 3329-3333
Citation: Awa. Lensing et Mh. Prins, Recurrent deep vein thrombosis and two coagulation factor gene mutations: Quo vadis?, THROMB HAEM, 82(6), 1999, pp. 1564-1566
Authors:
Prandoni, P
Lensing, AWA
Bagatella, P
Simioni, P
Girolami, A
Citation: P. Prandoni et al., Low rate of warfarin-related major bleeding in patients with recurrent venous thromboembolism, THROMB HAEM, 82(1), 1999, pp. 158-159
Authors:
Sanson, BJ
Lensing, AWA
Prins, MH
Ginsberg, JS
Barkagan, ZS
Lavenne-Pardonge, E
Brenner, B
Dulitzky, M
Nielsen, JD
Boda, Z
Turi, S
MacGillavry, MR
Hamulyak, K
Theunissen, IM
Hunt, BJ
Buller, HR
Citation: Bj. Sanson et al., Safety of low-molecular-weight heparin in pregnancy: A systematic review, THROMB HAEM, 81(5), 1999, pp. 668-672
Authors:
Planes, A
Samama, MM
Lensing, AWA
Buller, HR
Barre, J
Vochelle, N
Beau, B
Citation: A. Planes et al., Prevention of deep vein thrombosis after hip replacement - Comparison between two low-molecular-weight heparins, tinzaparin and enoxaparin, THROMB HAEM, 81(1), 1999, pp. 22-25
Citation: Awa. Lensing, Surrogate endpoints for the assessment of efficacy in venous thromboembolism treatment trials, HAEMOSTASIS, 28, 1998, pp. 127-130